Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy

Journal of Oral Pathology and Medicine

Volumn 29, Issue 7, 2000, Pages 336-341

  Schmidt Westhausen, Andrea M ^a,b   Priepke, Frank ^a   Bergmann, Frank J ^a   Reichart, Peter A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HIV infection; Oral manifestations; Therapy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; DRUG COMBINATION; FEMALE; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; MOUTH DISEASE; NONPARAMETRIC TEST; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; VIRUS LOAD;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BERLIN; CD4 LYMPHOCYTE COUNT; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MOUTH DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VIRAL LOAD;

EID: 0033941494     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290708.x     Document Type: Article

References (39)

1. Holtzer CD, Jacobson MA, Hadley WK, et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS 1998; 12: 1931-2.
2. Forrest DM, Seminari E, Hogg RS, et al. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. Clin Infect Dis 1998; 27: 1379-85.
3. Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS 1999; 13: 415-8.
4. Pezotti P, Napoli PA, Acciani S, et al. Group ftTAS. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. AIDS 1999; 13: 249-55.
5. Mocroft A, Vella S, Benfield TL, et al. Group ftES. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-30.
6. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med 1996; 335: 1091-8.
7. d'Aquila RT, Hughes MD, Johnson VA, et al. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases. AIDS Clinical Trials Group Protocol 241 Investigators. Ann Intern Med 1996; 124: 1019-30.
8. US Department of Health and Human Services. Availability of updated HIV treatment guidelines. MMWR Morb Mortal Wkly Rep 1999; 48: 459.
9. + T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-6.
10. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997; 337: 725-33.
11. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1425-31.
12. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 354-8.
13. CDC. 1993 Revised classification system for HIV infection and expanded surveillance rase definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-30.
14. Moniaci C, Greco D, Flecchia G, Raiteri R, Sinicco A. Epidemiology, clinical features and prognostic value of HIV-1-related oral lesions. J Oral Pathol Med 1990; 19: 477-81.
15. Reichart PA, Gelderblom HR, Becker J, Kuntz A. AIDS and the oral cavity. The HIV infection: virology, etiology, origin, immunology, precautions and clinical observations in 110 patients. Int J Oral Maxillofac Surg 1987; 16: 129.
16. Barone R, Ficarra G, Gaglioti D, Orsi A, Mazzotta F. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 1990; 69: 169-73.
17. Silverman SJ, Gallo JW, McKnight ML, Mayer P, Desanz S, Tan MM. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 402-7.
18. Nielsen H, Bentsen KD, Hojtved L, et al. Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 1994; 23: 140-3.
19. Phelan JA, Begg MD, Lamster IB, et al. Oral candidiasis in HIV infection: predictive value and comparison of findings in injecting drug users and homosexual men. J Oral Pathol Med 1997; 26: 237-43.
20. EC-Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-91.
21. Silverman S, Migliorati C, Lozada-Nur F, Greenspan D, Conant M. Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males. J Am Dent Assoc 1986; 11: 187.
22. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989; 18: 554-64.
23. Phelan JA, Saltzman BR, Friedland GH, Klein RS. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1987; 64: 50-6.
24. McCarthy GM, Mackie ID, Koval J, Sandhu HS, Daley TD. Factors associated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 1991; 20: 332-6.
25. Kolokotronis A, Kioses V, Antoniades D, Mandraveli K, Doutsos I, Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994; 78: 41-6.
26. Hood S, Bonington A, Evans J, Denning D. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors. AIDS 1998; 12: 447-8.
27. Hoegl L, Thoma-Greber E, Röcken M, Korting HC. HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses 1998; 41: 321-5.
28. Revankar SG, Sanche SE, Dib OP, Caceres M, Patterson TF. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients. AIDS 1998; 12: 2511-3.
29. Furrer H, Egger M, Opravil M, et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med 1999; 340: 1301-6.
30. Ellepola ANB, Samaranayake LP. The in vitro post-antifungal effect of nystatin on Candida species of oral origin. J Oral Pathol Med 1999; 28: 112-6.
31. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443-5.
32. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998; 12: 1459-64.
33. Reichart PA, Langford-Kuntz A, Pohle HD. Epidemic oro-facial Kaposi's sarcoma (eKS) - report on 124 cases. Eur J Cancer B Oral Oncol 1993; 29: 187-9.
34. Syrjänen S, Valle SJ, Antonen J, et al. Oral Candida infection as a sign of HIV infection in homosexual men. Oral Surg Oral Med Oral Pathol 1988; 65: 36-40.
35. van Meter F, Gallo JW, Garcia-Rojas G, Tan MM, Silverman SJ. A study of oral candidiasis in HIV-positive patients. J Dent Hyg 1994; 68: 30-4.
36. Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 338-42.
37. Feldman JG, Chirgwin K, Dehovitz JA, Minkhoff H. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol 1997; 89: 346-50.
38. Porter SR, Scully C. HTV topic update: protease inhibitor therapy and oral health care. Oral Dis 1998; 4: 159-63.
39. Gripshover BM, Valdez H, Salata RA, Lederman MM. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitor. AIDS 1998; 12: 2513-4.